KYAN Technologies
KYAN Technologies Pte Ltd is a leader in functional precision medicine for oncology, revolutionizing cancer care with its Optim.AI™ platform. Developed by scientific founders from UCLA and NUS, Optim.AI™ is a combinatorial drug sensitivity platform that predicts the most effective treatment options for individual cancer patients using limited tumor tissue. The company offers two main solutions: Clinical Decision Support for personalized patient treatments and Biopharma R&D Services to accelerate drug development by efficiently solving large and complex search spaces. KYAN Technologies focuses on small data AI and functional precision medicine, aiming to bridge the cancer care gap and improve drug development and delivery. They are licensed by the Ministry of Health (Singapore) as a Clinical Laboratory.
KYAN Technologies
KYAN Technologies Pte Ltd is a leader in functional precision medicine for oncology, revolutionizing cancer care with its Optim.AI™ platform. Developed by scientific founders from UCLA and NUS, Optim.AI™ is a combinatorial drug sensitivity platform that predicts the most effective treatment options for individual cancer patients using limited tumor tissue. The company offers two main solutions: Clinical Decision Support for personalized patient treatments and Biopharma R&D Services to accelerate drug development by efficiently solving large and complex search spaces. KYAN Technologies focuses on small data AI and functional precision medicine, aiming to bridge the cancer care gap and improve drug development and delivery. They are licensed by the Ministry of Health (Singapore) as a Clinical Laboratory.